Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Active, Not Recruiting

A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

NCT04707248

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations
  • Arizona Oncology Associates, PC HOPE (A)A HOPE) Tucson, Arizona, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Florida Cancer Lake Mary Lake Mary, Florida, United States
  • Oklahoma University Oklahoma City, Oklahoma, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03141177

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution - 0077 Daphne, Alabama, United States
  • Local Institution - 0044 Goodyear, Arizona, United States
  • Local Institution - 0132 Tucson, Arizona, United States
  • Local Institution - 0133 Bakersfield, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, Not Recruiting

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

NCT03634540

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations
  • USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States
  • Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
  • Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

NCT03845166

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations
  • Exelixis Clinical Site #6 Duarte, California, United States
  • Exelixis Clinical Site #49 La Jolla, California, United States
  • Exelixis Clinical Site #7 Los Angeles, California, United States
  • Exelixis Clinical Site #84 Los Angeles, California, United States
View all 86 locations
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details

Related conditions